In contrast, a 54-week trial of liraglutide did not show significant motor improvement (MDS-UPDRS III), but daily living activities (MDS-UPDRS II) improved significantly, suggesting functional gains without direct motor benefit [57]
Tirzepatide is a dual-agonist targeting GLP-1 and GIP receptors, while retatrutide is a triple-agonist that also activates the glucagon receptor
For example, in the lungs, GLP-1s may reduce the inflammatory response, improve oxidative stress, regulate protease/anti-protease imbalance, improve airway mucus homeostasis and reduce airway remodeling to provide benefit in patients with COPD
Favor your abdomen during titration, avoid the thigh before workouts, and remember to extend your needle hold time from 6 seconds up to 10 seconds
Understanding What Causes Long COVID
When insulin resistance increases, circulating insulin levels rise as the body attempts to control blood glucose